Polymyxin B Dosage Guide: Research Protocols, Timing & Reconstitution

Standard Dosage Range

Research dosing range: 1.0–2.5 mg/kg/day divided q12h (IV/IM). Adjust based on renal function.

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Serious Gram-Negative Infections (CRE, CRAB, MDR Pseudomonas)

1.5–2.5 mg/kg/dayDivided q12h

Duration

7–21 days

Dosing based on ideal body weight (IBW) or adjusted body weight (AdjBW) in obese patients. Loading dose of 2.5-3.0 mg/kg may be considered in critically ill patients. Therapeutic drug monitoring recommended.

Ventilator-Associated Pneumonia (VAP)

1.5–2.0 mg/kg/dayDivided q12h

Duration

7–14 days

Higher end of dosing range recommended for infections with high bacterial burden or decreased susceptibility. Consider combination therapy with other antibiotics.

Bloodstream Infections (BSI)

1.5–2.5 mg/kg/dayDivided q12h

Duration

10–14 days

Duration based on source control and clinical response. Consider prolonged infusion (over 1-2 hours) to maximize AUC/MIC ratio.

Topical Ophthalmic Infections

1–3 drops every 1–6 hoursAs needed

Duration

Up to 7 days

Use polymyxin B sulfate with trimethoprim ophthalmic solution. Consult ophthalmologist for severe infections.

Topical Otic Infections

3-4 drops in affected ear(s)2-4 times daily

Duration

Up to 10 days

Use polymyxin B sulfate, neomycin, and hydrocortisone otic solution. Avoid in patients with perforated tympanic membrane.

Timing & Frequency

Administer intravenously or intramuscularly. For severe infections, ensure timely administration after diagnosis to improve outcomes. Topical formulations administered directly to affected area.

Cycle Guidance

Polymyxin B is typically administered for the duration of the acute infection. Prolonged or repeated courses should be avoided due to the risk of nephrotoxicity and neurotoxicity. Monitor renal function closely.

Reconstitution Reference

Quick reference for reconstituting Polymyxin B. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size	50 mg vial
BAC Water Volume	2 mL sterile water for injection for a concentration of 25 mg/mL
Concentration & Draw	Varies based on dilution. Example: 50 mg vial reconstituted with 2 mL yields 25 mg/mL. Consult pharmacy reference for specific dilutions.
Storage	Refrigerate reconstituted solution and use within 7 days. Lyophilized powder can be stored at room temperature.
Stability	Reconstituted solution stable for up to 7 days refrigerated. Lyophilized powder stable until expiration date on vial.

Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What are the common side effects of Polymyxin B?

Nephrotoxicity (acute kidney injury) is the most significant side effect. Neurotoxicity (dizziness, ataxia, paresthesias) can also occur. Monitor renal function and neurological status closely. Other side effects include fever, rash, and injection site reactions.

Is Polymyxin B safe to use in patients with renal impairment?

Polymyxin B should be used with extreme caution in patients with renal impairment. Dosage adjustments are necessary based on creatinine clearance. Therapeutic drug monitoring is recommended. Avoid concurrent use of other nephrotoxic medications.

Can Polymyxin B be used during pregnancy or breastfeeding?

Polymyxin B is generally avoided during pregnancy unless the potential benefit outweighs the risk to the fetus. Limited data are available on excretion in breast milk; caution is advised during breastfeeding.

How is Polymyxin B administered?

Polymyxin B is typically administered intravenously or intramuscularly. It can also be used topically in ophthalmic and otic formulations.

What is the mechanism of action of Polymyxin B?

Polymyxin B binds to lipopolysaccharide (LPS) in the outer membrane of gram-negative bacteria, disrupting membrane integrity and leading to cell death. It also neutralizes circulating endotoxin.